» Articles » PMID: 9717844

Estrogen Receptor, a Common Interaction Partner for a Subset of Nuclear Receptors

Overview
Journal Mol Endocrinol
Date 1998 Aug 26
PMID 9717844
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Nuclear receptors regulate transcription by binding to specific DNA response elements as homodimers or heterodimers. Herein, the yeast and mammalian two-hybrid tests as well as glutathione-S-transferase pull-down assays were exploited to demonstrate that estrogen receptor (ER) directly binds to a subset of nuclear receptors through protein-protein interactions between ligand-binding domains. These receptors include hepatocyte nuclear factor 4, thyroid hormone receptor (TR), retinoic acid receptor (RAR), ERbeta, and retinoid X receptor (RXR). In yeast cells, a LexA fusion protein to the human ER ligand-binding domain (LexA/ER-LBD) was an inert transactivator of a LacZ reporter gene controlled by upstream LexA-binding sites. However, LexA/ER-LBD differentially modulated the LacZ reporter gene expression when coexpressed with native TRs, RARs, or RXRs. Similarly, cotransfection of these receptors in CV1 cells up- or down-regulated transactivations by ER. From these results, we propose that ER is a common interaction partner for a subset of receptors, and these interactions should mediate novel signaling pathways in vivo.

Citing Articles

ESR1 ChIP-Seq Identifies Distinct Ligand-Free ESR1 Genomic Binding Sites in Human Hepatocytes and Liver Tissue.

Collins J, Huo Z, Wang D Int J Mol Sci. 2021; 22(3).

PMID: 33540646 PMC: 7867289. DOI: 10.3390/ijms22031461.


Health benefits attributed to 17α-estradiol, a lifespan-extending compound, are mediated through estrogen receptor α.

Mann S, Hadad N, Nelson Holte M, Rothman A, Sathiaseelan R, Ali Mondal S Elife. 2020; 9.

PMID: 33289482 PMC: 7744101. DOI: 10.7554/eLife.59616.


Nuclear Receptors, Ligands and the Mammalian B Cell.

Jones B, Penkert R, Surman S, Sealy R, Hurwitz J Int J Mol Sci. 2020; 21(14).

PMID: 32679815 PMC: 7404052. DOI: 10.3390/ijms21144997.


The flavonoid agathisflavone modulates the microglial neuroinflammatory response and enhances remyelination.

de Almeida M, Pieropan F, de Mattos Oliveira L, Coelho Dos Santos Junior M, David J, David J Pharmacol Res. 2020; 159:104997.

PMID: 32534098 PMC: 7482432. DOI: 10.1016/j.phrs.2020.104997.


Nuclear receptor crosstalk - defining the mechanisms for therapeutic innovation.

De Bosscher K, Desmet S, Clarisse D, Estebanez-Perpina E, Brunsveld L Nat Rev Endocrinol. 2020; 16(7):363-377.

PMID: 32303708 DOI: 10.1038/s41574-020-0349-5.